Skip to main content
Clinical Trials/PACTR202401785557046
PACTR202401785557046Not yet recruitingPhase 4

Injection of Hyaluronic Acid versus Corticosteroid in Management of Plantar Fasciitis: Randomized Clinical Trial

Mohammed VI University Hospital0 sites50 target enrollmentStarted: January 6, 2024Last updated:

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 Year(s) to 44 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age: 20 and 60 years
  • Chronic talalgia (3 months), resistant to conservative treatment: rest, insoles, physical treatment (such as deep transverse massages, stretching, shock waves, etc.), and NSAIDs.
  • Clinical diagnosis of PA: Pain initiated or aggravated by exertion and pain on palpation of the enthesis.
  • Absence of fissures detected in ultrasound examinations.
  • Visual Analog Scale (VAS) pain > 3/10

Exclusion Criteria

  • Plantar fascia surgery
  • Shock waves within the last 3 months
  • A corticosteroid or PRP injection in the last 3 months
  • Bilateral plantar fasciitis
  • Uncontrolled diabetes mellitus
  • Chronic inflammatory rheumatism (spondyloarthritis)
  • Tarsal tunnel syndrome
  • Infection or local trauma near the injection site.

Investigators

Sponsor
Mohammed VI University Hospital

Similar Trials